miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1.
about
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewDeregulated miRNAs in human cervical cancer: functional importance and potential clinical use.Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.MicroRNA-144 regulates proliferation, invasion, and apoptosis of cells in malignant solitary pulmonary nodule via zinc finger E-box-binding homeobox 1.Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients.Downregulation of CCR5 inhibits the proliferation and invasion of cervical cancer cells and is regulated by microRNA-107MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancerMicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer.MicroRNAs in gynecological cancers: Small molecules with big implications.Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
P2860
Q26785539-8C2643BB-5118-4BAA-A76A-6ACE1AD2C05FQ30241934-4011FB94-9229-4B48-8954-318F70E4F66DQ33915812-2EDD8A9B-9BDD-4ADD-B612-06FBF805927CQ35854478-9804F76B-28F4-4245-BF4C-6441190BE6D7Q35955325-F5E4F11B-6C59-4BDB-A616-2BFB48E613F8Q36524621-2AF284D1-605A-45D3-9316-B08827BC03D5Q36729381-690D1969-033B-4BF3-BA42-14C3A11C968BQ37252703-624C598F-73C9-4408-A1AE-5F9285141D6EQ37407111-8FD4D0C0-5A6A-48C0-8A72-E755F0C35FBDQ39333266-9B3B4D2D-424A-484B-9AD1-402D5463E226Q41573201-6A969FF6-0A94-4003-BB37-16E6568617FCQ46941249-928C2B71-8C84-4A93-A6F5-F0462ED2CDA1Q48225109-4CA966FB-866B-4575-9742-E6920F146BCDQ52648392-1AF394DB-108B-4B2C-B568-BC209E7F2170
P2860
miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@ast
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@en
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@nl
type
label
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@ast
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@en
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@nl
prefLabel
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@ast
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@en
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@nl
P2093
P2860
P1433
P1476
miR-107 activates ATR/Chk1 pat ...... er invasion by targeting MCL1.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0111860
P407
P577
2014-11-11T00:00:00Z